This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Genevive, Inc.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovative Contributions of Kareem L Graham
Introduction
Kareem L Graham is an accomplished inventor based in Brisbane, California. He has made significant strides in the field of immunotherapy through his innovative research and development of therapeutic peptides. His work focuses on utilizing microbially derived peptides and proteins to address various human diseases.
Latest Patents
Kareem holds a patent for "Microbially derived peptides and proteins for immunotherapy." This patent discloses therapeutic peptides and pharmaceutical compositions that have utility in treating a range of human diseases. The therapeutic peptides are particularly useful as immunotherapeutics, aimed at modulating regulatory and effector molecules of the mammalian immune system to mitigate disease.
Career Highlights
Kareem L Graham has established himself as a key figure in the biotechnology sector. His work at Genevive, Inc. showcases his commitment to advancing medical science and improving patient outcomes through innovative therapies. His research has the potential to revolutionize the way certain diseases are treated.
Collaborations
Kareem collaborates with talented professionals in his field, including Yuliya Katlinskaya and Helena Kiefel. These partnerships enhance the research and development efforts at Genevive, Inc., fostering an environment of innovation and creativity.
Conclusion
Kareem L Graham's contributions to immunotherapy through his patented work exemplify the impact of innovative thinking in medicine. His dedication to advancing therapeutic options highlights the importance of research and collaboration in the fight against human diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile